Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation

Inclusion Criteria: Participants must meet the following criteria: 1. The patient signed an informed consent form and voluntarily participated in the study. 2. Patients undergoing HLA haploidentical allogeneic hematopoietic stem cell transplantation; 3. Age ≥18 years, regardless of gender 4. ECOG score 0-2 5. Expected survival ≥3 months 6. No severe impairment of function of major organs Exclusion Criteria: If any of the following criteria are met, the participants must be excluded from this research project: 1\) Patients with known allergy to TPO-RAs; 2) Patients who cannot take oral medication due to gastrointestinal symptoms, altered mental status, etc. during transplantation; 3) Other reasons for exclusion as determined by the investigator. \-